Hu, Junjie <br/><br/>
Complement C3a receptor antagonist attenuates tau hyperphosphorylation via glycogen synthase kinase 3β signaling pathways.  [electronic resource] 

 -  European journal of pharmacology  May 2019 
 - 135-140 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1879-0712 
<br/><br/><label>Standard No.: </label>10.1016/j.ejphar.2019.02.020  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Cell Line, Tumor<br/>Cell Survival--drug effects<br/>Cytoskeleton--drug effects<br/>Glycogen Synthase Kinase 3 beta--metabolism<br/>Humans<br/>Okadaic Acid--pharmacology<br/>Phosphorylation--drug effects<br/>Receptors, Complement--antagonists & inhibitors<br/>Signal Transduction--drug effects<br/>tau Proteins--metabolism